Connect with us

Published

on

We Are Aware Of Lassa Fever Outbreak In Kaduna State, Says NCDC Boss—-Dr Jide Idris, Director General of the Nigeria Centre for Disease Control and Prevention (NCDC), has officially acknowledged the outbreak of Lassa fever in Kaduna State.

Speaking to newsmen on Friday in Abuja, Idris confirmed that the NCDC was closely monitoring the situation and working in collaboration with state health authorities to contain the spread of the disease.

The News Agency of Nigeria (NCDC) reports that Lassa fever is an acute viral hemorrhagic (excessive bleeding) illness that is transmitted to humans through contact with food or household items contaminated by infected rodents or contaminated persons.

Its symptoms include fever, headache, sore throat, general body weakness, cough, nausea, vomiting, diarrhoea, muscle pains, chest pain, and in severe cases, unexplainable bleeding from ears, eyes, nose, mouth, and other body openings.

Idris said “the NCDC was notified yesterday by the Kaduna State Ministry of Health of the report of deaths from suspected viral hemorrhagic fever at the 44 Nigerian Army Reference Hospital in Kaduna.

“Following this notification, the centre has been working with both institutions to conduct comprehensive investigation of the suspected cases, as well as ramp up response activities.

“Four of the six blood samples from suspected cases sent to the Bayero University Teaching Hospital in Kano have been confirmed for Lassa fever. Furthermore, twenty-five close contacts of all these cases are now under follow-up and placed on prophylactic medicine.

“The state’s Ministry of Health has also activated the Incident Management System with all the response pillars including intensified risk communication and community engagement for the prevention and control of Lassa fever in the affected communities.”

According to him, the NCDC has dispatched rapid response teams to the affected areas in Kaduna State to conduct epidemiological investigations and implement necessary control measures.

He emphasised the importance of early detection, prompt treatment, and community engagement in curbing the spread of the disease.

“Lassa fever is a viral hemorrhagic fever caused by the Lassa virus, which is transmitted to humans through contact with food or household items contaminated with rodent urine or faeces.

“The disease is endemic in Nigeria, with sporadic outbreaks occurring primarily during the dry season,” he said.

He urged healthcare workers and the public to maintain strict hygiene practices, including proper food storage and disposal of waste, to reduce the risk of Lassa fever transmission.

He also advised individuals experiencing symptoms such as fever, headache, sore throat, and muscle aches to seek medical attention immediately, as early diagnosis and treatment can significantly improve outcomes.

The NCDC DG reassured the public that the agency was committed to containing the outbreak and protecting the health of Nigerians.

He urged citizens to remain vigilant and report any suspected cases to the nearest health facility or state health authorities for prompt response.

“As the situation develops, the NCDC will continue to provide updates and guidance to the public to ensure effective control and prevention of Lassa fever in Kaduna State and across Nigeria,” he said.

According to him, as of Feb. 18, 2024 (end of week 7), 84 local government areas in 23 states of the country have reported a total of 2,621 suspected cases, 476 confirmed, and 84 deaths with a case fatality rate of 18.6 per cent.

“Our condolences go to the families and friends of those (including the health workers) who lost their lives to this disease across the country,” he said.

He added that the agency, through the recently activated multi-sectoral multi-disciplinary Incident Management System has taken the following actions:

“Distribution of medical supplies for case management, infection prevention and control, laboratory diagnosis, in all  Lassa fever treatment centres in the country.

“capacity building exercises of some healthcare workers across all the geopolitical zones on Lassa fever preparedness, readiness, and response through the pilot Lassa fever clinical management fellowship.

“Distribution of Lassa fever social and behaviour change communication (SBC) materials to all the 36 states and FCT,” he explained.

He called for a holistic approach to addressing public health challenges in the country, saying “we will be introducing a significant perspective on tackling complex public health issues in the country.”

0Shares
Continue Reading
Click to comment

Leave a Reply

News

Sri Lanka on Alert as Nipah Virus Cases Emerge in Eastern India

Published

on

Nipah Virus Cases Emerge in Eastern India

Sri Lanka on Alert as Nipah Virus Cases Emerge in Eastern India—-Sri Lanka has stepped up monitoring measures following reports of a Nipah virus cluster in India’s eastern state of West Bengal.

Health authorities across parts of Asia have also heightened vigilance over the emerging situation, the Daily Mirror reported.

Health officials said Sri Lanka is tracking developments at the regional level and remains in contact with international health monitoring systems.

While no cases have been reported locally, authorities have indicated that preparedness measures are in place should the situation evolve.

The alert follows confirmation by Indian authorities of at least five Nipah virus infections in West Bengal, including cases among healthcare workers.

The development has prompted several countries in the region to strengthen preventive measures, particularly at international airports.

Nipah virus is a zoonotic disease transmitted between animals and humans and, in some instances, through human-to-human contact.

It is classified as a priority pathogen by the World Health Organisation due to its epidemic potential and the severity of illness it can cause. Past outbreaks of the Nipah virus have been associated with high fatality rates, ranging from 40 per cent to 75 per cent. (Xinhua/NAN)

0Shares
Continue Reading

Health & Wellbeing

EL-LAB Limited Marks 2025 World Quality Week With innovation

Published

on

EL-LAB Limited Marks 2025 World Quality Week With innovation

EL-LAB Limited Marks 2025 World Quality Week With innovation

 

EL-LAB Medical Diagnostics and Research Centre, Nigeria’s leading ISO-certified diagnostic centre, today announced its dedication to global quality standards, marking World Quality Week 2025 with the theme “Quality: Think differently” and highlighting its ISO 15189:2022 accreditation.

The centre, which was established in 1998 (27 years ago), has provided advanced medical testing services across Lagos State and continues to contribute significantly to the development of the Nigerian health sector.

Quality: The Silent Foundation of Clinical Decisions

In a statement issued by the company, Mrs. Blessing Nwakobi, Quality Assurance Manager, emphasized that Quality Assurance is the cornerstone of reliable medical diagnosis.

“In healthcare, laboratories are the silent foundation of clinical decisions. Most medical diagnoses rely on accurate laboratory results, thereby making Quality Assurance fundamental to patient safety and clinical excellence,” Mrs. Nwakobi stated

Through the successful transition to the ISO 15189:2022 standard—the highest international benchmark for medical laboratories—EL-LAB demonstrates its unwavering commitment to excellence, impartiality, and safety. This accreditation ensures that the centre’s quality management system is not merely compliant, but a living culture of competence and continual improvement.

The system is strategically built on principles including:

Patient Centred Services
Risk-Based Thinking
Continuous Improvement

·       Staff engagement, Competence and Training

This risk-based approach ensures that all activities which pose a risk to patients are managed proactively, assuring the best possible outcomes across the entire testing process

The robust quality management strategy integrates comprehensive mechanisms to guarantee the integrity of every result. Quality assurance at EL-LAB involves the strict adherence to Standard Operating Procedures (SOPs), vigorous Internal Quality Control (IQC) checks, and mandatory validation via External Quality Assessment (EQA).

These programs ensure that every test result is accurate, reproducible, reliable, and comparable with global benchmarks, reinforcing reliability and building public trust in every report issued by the laboratory.

Addressing the 2025 Quality Week theme, “Quality: Think differently,” EL-LAB’s leadership urged healthcare professionals to challenge traditional quality approaches.

“We believe thinking differently about quality begins with one powerful shift: seeing quality not as an act, but as an attitude”. “Quality is what we do when no one is watching and it shows in how we treat our patients, our colleagues, and our work. The ISO 15189:2022 accreditation is a reminder that quality is not a destination, but a journey of continuous improvement.”

EL-LAB invites all partners, colleagues, and stakeholders in the healthcare ecosystem to join them in thinking differently, noting that the future of diagnostic excellence depends on embracing change today.

About EL-LAB Medical Diagnostics and Research Centre

Established in 1998, EL-LAB Medical Diagnostics and Research Centre is a leading ISO-certified medical laboratory providing advanced, reliable, and comprehensive diagnostic services across Nigeria. Dedicated to clinical excellence and patient safety, EL-LAB leverages state-of-the-art technology and a highly competent workforce to deliver results that form the trusted foundation of patient care.

0Shares
Continue Reading

Trending

0Shares